Sample Healthcare Paper on Mobile Applications on AIDS info

Mobile health applications have eased access to healthcare services and reduced the overall costs directed towards healthcare services by different populations. The ability to utilize mobile medical apps on both mobile phones and web-based platforms eases access to critical information. The AIDSinfo mobile application is one of the mobile applications that have proven useful for people diagnosed with HIV/AIDS and the overall population.

Name

The name of the mobile application identified is AIDS info. The app provides information to users on the latest information related to HIV/AIDS. It provides people living with HIV and the public with information on the prevention and treatment of HIV/AIDS and data on clinical trials and access to research-related information on HIV/AIDS (AIDSinfo, 2020). The mobile application focuses on HIV/AIDS information.

Author

The Department of Health and Human Services in the US sponsored the development of the mobile application with the aim of improving access to useful information on HIV/AIDS and its management. The National Library of Medicine (NLM) maintains the mobile application.  Access to the information available on the application is free; thus, users do not need to subscribe to other application-related fees (AIDSinfo, 2020). The NLM is also responsible for uploading updated information regarding HIV/AIDS on the application.

Endorsement

The app is FDA-approved. It offers information approved by the national government regarding HIV/AIDS. The app’s reliability is based on the involvement of the national government in approving the information posted for users and the role of the NLM in managing and regulating the information released to users (AIDSinfo, 2020). The approval of the AIDSinfo by the national government and the FDA has promoted its success.

Operation

The app works effectively on smartphones. The application can be downloaded from the Google play store and is developed with specifications that ensure its compatibility with both iOS and Android phones. Individuals interested in using the application can download it on their smartphones, iPad, or iPad touch. Information found on the application can also be accessed through a computer on the web-based version. The appropriateness of the mobile-based version is also based on the accessibility and portability of mobile phones, ease in downloading the app from the play store, and availability of internet connectivity (AIDSinfo, 2020). This ensures that users can access the information easily, regardless of their location.

Aesthetics

The AIDSinfo application is displayed in a manner that makes it easy to use. The layout used for the mobile application is easy to navigate, making it easy for users to search for specific information. The application was created with a simple layout to ensure that it would serve populations from different age groups. It can be used without instructions. The layout of the app outlines six different subdivisions, which include; the home page, list of drugs used for treatment, general information on the condition, clinical trials, research studies, and national guidelines (AIDSinfo, 2020). Users can select the segment they wish to explore based on the information they are interested in checking.

Purpose

The AIDSinfo application was created to make HIV/AIDS information easy to access. It was developed as part of the government’s intervention to reduce stigma related to HIV/AIDS by helping the public understand the management of HIV/AIDS, its pathophysiology, risks of infection, prevention mechanisms, and availability of medication. The application was developed to ensure that infected individuals and healthcare providers have access to updated information regarding the condition, changes in drugs used for its management, the discovery of new treatment plans, and other details concerning the impact of the disease on their lives (AIDSinfo, 2020). It contains information on the management of HIV/AIDS in children, adolescents, and adults, making it suitable for users from different age groups.

Clinical Decision-Making

The application can influence clinical decision-making among healthcare providers. Since it provides information on recent updates regarding HIV/AIDS prevention, management, and treatment based on clinical trials and research published in peer-reviewed journals, healthcare practitioners can use it to access relevant information on the management of their patients. The application is focused on HIV/AIDS and can be used by healthcare practitioners to ease their search for clinical trials that address the exact problems affecting their patients. Healthcare practitioners can use the research studies posted on the app to examine the cause of drug intolerances or adverse reactions seen in their patients (Nibbelink & Brewer, 2018; Baig, Hosseini, Moqeem, Mirza, & Linden, 2017). They can also access recent data on new drugs, which might be suitable for patients experiencing adverse reactions from the drugs that were initially in the market. The availability of a wide range of research-related data makes the app suitable for clinical decision-making among healthcare providers.

Safety

There is little to no potential for patient harm associated with the utilization of the AIDSinfo application. The information posted on the application is reliable and safe and can be used by patients to understand their conditions and the role of their medication in managing HIV/AIDS. The NLM’s role in maintaining the app and the involvement of other national health organizations such as the FDA ensures that the information posted on the site is safe. Additionally, the application contains peer-reviewed studies, which support the information posted. The NLM ensures that the information posted on the app is evidence-based and clear (AIDSinfo, 2019). These factors promote the app’s safety.

Privacy/Security

The app contains a section that provides users with information on its privacy policy. The section assures users that the app does not collect any personal, identifiable information, or about their utilization of the application. The privacy policy also offers users details on the kind of information collected by the app, which includes the domain name used to access the app, search terms used on the app, version of mobile phone or computer operating system used to access the app, and third-party websites and applications affiliated with the AIDSinfo app. The app does not share users’ information on social networks. Users are notified in the event of a breach(AIDSinfo, 2017). These factors ensure that people can use the app without worrying about their personal data.

User

The app was developed for individuals infected and affected with HIV/AIDS, healthcare workers, and the public. The general population and community health workers use the app for education, while healthcare providers use it for clinical decision-making and updates on HIV/AIDS management (AIDSinfo, 2020). Users can access a wide range of information on HIV/AIDS from the app.

Distribution

The app was created to be used by the overall population and for wider distribution. Users living in any part of the U.S. can access the app, as it was an initiative developed through the collaboration on the government, the FDA, and the NLM (AIDSinfo, 2020). The affordability of smartphones also makes the distribution of HIV/AIDS information through the app easy.

Credibility

The app uses sources, such as national guidelines and peer-reviewed research, which makes the information reliable and credible. The research articles on the application are obtained from health databases, like Cochrane and PubMed (AIDSinfo, 2020). NLM’s role in managing the information posted on the app also proves its credibility.

Relevance

The app offers relevant information to its users. It was lat updated on June 7, 2020. The information is updated based on recent findings from research studies on HIV/AIDS. Updates on HIV/AIDS treatment aligns with research and guidelines on HIV/AIDS (Bhatti, Usman, & Kandi, 2016; AIDSinfo, 2020). The content published on the website is consistent with evidence-based standards and literature as it relies on data from clinical trials and research on HIV/AIDS.

Clinical Scenario

Patient Age-Population

The clinical scenario is based on an adult male, Michael Huston. The patient is 38 years old. He was diagnosed with HIV/AIDS eight months ago and has been on medication ever since. He has been consistent in taking his medication and adhering to treatment recommendations offered to him.

Clinical Setting

The patient was admitted to a hospital after complaining about experiencing the possible side effects of the drugs he was using. The patient was admitted to a unit set aside for patients diagnosed with HIV/AIDS or its complication and opportunistic infections affecting HIV/AIDS patients. A community healthcare worker assigned with the role of conducting follow-ups referred the patient to the healthcare facility.

Illness and Diagnosis

The clinical scenario is based on a HIV/AIDS infected male. He was diagnosed with the condition eight months ago. He complains of experiencing unusual fatigue, shortness of breath, unusual muscle weakness, lightheadedness, nausea, and vomiting. He currently weighs 152 pounds, is 175 cm tall, and his BMI is 22.5 kg/m2. Based on his last assessment, he has lost approximately 12 pounds over the past two weeks. He has a low appetite and suspects his medication has contributed to his current state. He stated that his symptoms began shortly after the initiation of his treatment. His current diagnosis is a possible adverse drug reaction associated with the use of antiretroviral therapy drugs.

Application Usage

The application will be implemented during the assessment and intervention phase. The healthcare practitioner and the patient will use it. The healthcare practitioners will use the app to obtain information about the different drugs used by the patient and compare the side effects and adverse reactions associated with the drug with the symptoms presented by the patient. The healthcare practitioner will also use the app to determine alternative drugs for the patient based on the research from peer-reviewed sources available on the app and recent updates on HIV/AIDS treatment recommendations (Bhatti et al., 2016; Gunthard et al., 2016). The patient will use the app to read about the side effects of the drugs he was using and those associated with his new treatment to reduce risks of future complications.

The utilization of medical applications has also reduced the need for frequent hospital visits among individuals diagnosed with chronic illnesses. The development of these applications continues to improve the quality of healthcare services. The AIDSinfo app is a useful mobile application that provides HIV/AIDS patients and caregivers easy access to HIV/AIDS information.

 

 

References

AIDSinfo. (2017, February). Privacy Policy. AIDSinfo.https://aidsinfo.nih.gov/privacy-policy

AIDSinfo. (2019, April 30). Infographics. AIDSinfo.https://aidsinfo.nih.gov/understanding-hiv-aids/infographics/25/fda-approval-of-hiv-medicines

AIDSinfo. (2020, June 7). About. AIDSinfo. https://aidsinfo.nih.gov/about-us

AIDSinfo. (2020, February 12). AIDSinfo.Privacy Policy.https://aidsinfo.nih.gov/privacy-policy

AIDSinfo. (2020, February 12). Apps. AIDSinfo. https://aidsinfo.nih.gov/apps

AIDSinfo. (2020, February 11). Understanding HIV/AIDS.AIDSinfo. https://aidsinfo.nih.gov/understanding-hiv-aids

Baig, M. M., Hosseini, H. G., Moqeem, A., Mirza, F., & Linden, M. (2017). Clinical decision support systems in hospital care using ubiquitous devices: Current issues and challenges. Health Informatics Journal, 25(3). https://journals.sagepub.com/doi/full/10.1177/1460458217740722.

Bhatti, A. B., Usman, M., & Kandi, V. (2016). Current Scenario of HIV/AIDS, Treatment Options, and Major Challenges with Compliance to Antiretroviral Therapy. Cureus, 8(3), e515. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818110/.

Gunthard, H. F., Saag, M. S., Benson, C. A., Rio, C. d., Eron, J. J., Gallant, J. E., . . . Volberding, P. A. (2016). Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA, 316(2), 191-210. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012643/.

Nibbelink, C. W., & Brewer, B. B. (2018). Decision-Making in Nursing Practice: An Intergrative Literature Review. Journal of Clinical Nursing, 27(5-6), 917-928. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867219/.